This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
EAU 2025
SES AUA 2025
Thought Leaders 2025
APCCC Diagnostics 2025
ASCO GU 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2018
AUA 2018
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions / Nocturia
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2018 Prostate Cancer
Viewing 81-100 of 109 articles
AUA 2018: Implementation of a Novel Point of Care PCR Test to Guide Antibiotic Prophylaxis Prior to Transrectal Prostate Biopsy
AUA 2018: Engaging the Immune System to Combat Prostate Cancer
AUA 2018: Long-Term Impact of 7-year Finasteride Therapy on Prostate Cancer Incidence and Disease-Specific Mortality
AUA 2018: Donald S. Coffey Lecture
AUA 2018: Journal of Urology: Top Papers in Prostate and Testis
AUA 2018: MRI-Guided Transurethral Ultrasound Ablation in Patients with Localized Prostate Cancer: 3-Year Outcomes of a Prospective Phase I Study
AUA 2018: Population-Based Outcomes of Men with a Single Negative Prostate Biopsy: Importance of Continued Follow Up Among Older Patients
AUA 2018: Disparities in the Diagnosis and Management of Metastatic Prostate Cancer in Young Men
AUA 2018: Prostate Cancer Incidence and Mortality among Men using Statins and Non-Statin Lipid-Lowering Medications
AUA 2018: Association between Androgen-Deprivation Therapy and Non-Prostate Cancer Mortality among Men with Non-Metastatic Prostate Cancer
AUA 2018: Who Dies from Prostate Cancer? A Comprehensive Analysis of a Large Series of Patients Treated with Radical Prostatectomy with Long-Term Follow-Up
AUA 2018: Oncologic Surveillance After Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients: A Novel Risk-Based Approach
AUA 2018: Overall Survival in Patients with Primary Bone Metastatic Prostate Cancer Receiving ADT or ADT plus Concurrent Radiation Therapy: HORRAD Trial
AUA 2018: Prostate Cancer Tumor Board
AUA 2018: Health-Related Quality of Life in Patients with mCRPC Treated with Cabazitaxel, CAPRISTANA
AUA 2018: Neoadjuvant Enzalutamide and ADT in High-Risk Prostate Cancer: Initial Imaging and Surgical Findings from a Phase II Clinical Trial
AUA 2018: Clinical Experience with Lutetium 177-labeled PSMA-I&T for Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer
AUA 2018: Other Malignancies prior Prostate Cancer Diagnosis – Clinical Outcome after Radical Prostatectomy
AUA 2018: Predictors of Radiographic Progression in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone: Retrospective Analysis of COU-AA-302
AUA 2018: The Impact of Prior Local Therapy on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer: Results from SEARCH
1
2
3
4
5
6
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free